Please ensure Javascript is enabled for purposes of website accessibility
Accueil > Support > Références

Design of Orally-bioavailable Tetra-cyclic phthalazine SOS1 inhibitors with high selectivity against EGFR

Date de publication : 2023-07-01  Nombre de vues : 30
Recommandation

Obtenir un devis gratuit